Taiwan Food and Drug Administration (TFDA) collaborates with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host the 11th Joint Conference of Taiwan and Japan on Medical Products Regulation on October 5th, 2023 at National Biotechnology Research Park in Taipei. The conference aims to enhance the exchange of regulatory information between two sides, foster the cooperation between the bilateral officials and the industries, and assist the industry to expand the international market, while protecting the health and well-being of the public.
Since the “Framework of the Cooperation on the Medical Products Regulation” was signed by Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, both sides have hosted Annual Joint Conferences in alternating turns for eleven years. This year, the representatives from TFDA, MHLW and PMDA share the latest information on medical products regulations, as well as other important topics such as RWD/RWE for Accelerating Clinical Development, New Drug Review Cooperation between Japan and Taiwan, Regenerative Medicinal Products Regulation, Cybersecurity for Medical Devices and updates on medical devices regulation. The conference will also be streamed live for virtual attendees via Webex. Both officials and industries will join the conference with about 800 people participating. We hope that through this conference, the industry from both sides will gain a better understanding of the regulations and create a new blueprint for the collaboration between Taiwan and Japan on medical products regulations.
Sources：Ministry of Health and Welfare
